PR84634

BUFFALO GROVE, Illinois, July 2, 2020 /PRNewswire=KYODO JBN/ --

- COMPANY'S NEWLY EXPANDED TRIS AMINO MANUFACTURING FACILITY IN GERMANY

PROVIDES THE MARKET WITH A DUAL ANGUS MANUFACTURING SOURCE FOR INDUSTRIAL,

PERSONAL CARE AND ULTRA PURE MULTICOMPENDIAL-GRADE TRIS BUFFER PRODUCTS

ANGUS Chemical Company ("ANGUS" or "Company"), the world's largest and only

fully integrated original manufacturer of TRIS buffers, today announced the

full commercial launch of the Company's new TRIS AMINO(TM) AC (ADVANCED

CRYSTAL) buffer portfolio (

https://c212.net/c/link/?t=0&l=en&o=2847037-1&h=1127751871&u=https%3A%2F%2Fangus.com%2Fmarkets%2Flife-sciences%2Fbiotechnology%2Ftris-amino-ac&a=TRIS+AMINO%E2%84%A2+AC+(ADVANCED+CRYSTAL)+buffer+portfolio

). TRIS AMINO AC buffers are manufactured at the Company's newly expanded cGMP

production facility in Ibbenburen, Germany, providing the market with a dual

manufacturing source for ANGUS' industrial, personal care and

multicompendial-grade TRIS AMINO tromethamine buffers.

Logo - https://mma.prnewswire.com/media/460234/ANGUS_Chemical_Company_Logo.jpg

"ANGUS continues to invest in capacity expansion to meet the surging global

demand for TRIS AMINO buffers in both highly regulated and industrial

applications," said Laura Kaepplinger, Global Segment Leader for ANGUS Life

Sciences. "At the same time, we developed and introduced several process

innovations in our Ibbenburen manufacturing facility that enable us to address

some of the challenges related to handling, storage and use of TRIS buffers due

to the hygroscopic nature of the chemistry."

Clumping during transport and storage is a well-known and challenging

characteristic of conventional TRIS buffers that can delay processes, reduce

productivity and create operational bottlenecks related to time spent manually

breaking apart aggregates and extended mixing time. To address this

long-standing industry challenge, ANGUS created a novel solution to the

clumping problem, without any additives or changes to the molecule itself.

"We leveraged decades of ANGUS TRIS manufacturing expertise to develop the

proprietary process and technology used to produce the unique crystal

morphology of our new TRIS AMINO AC buffers," said Dr. Dave Green, Vice

President, ANGUS Research and Development. "With a larger, more rounded

particle structure, TRIS AMINO AC buffers are less prone to clumping and

hardness even when subjected to the more aggressive handling and storage

conditions."

The unique crystalline structure of TRIS AMINO AC buffers may provide critical

operational benefits and cost savings opportunities to facilities that

routinely prepare and mix large-scale TRIS buffer solutions, including:

    -- Less time and energy required to break up clumps due to low

interparticle cohesion

    -- More efficient dispensing and transport through conveyors

    -- Lower dust emissions due to fewer fine particles

    -- Exceptional purity without additives or anti-clumping agents

ANGUS' state-of-the-art production facility in Ibbenburen is designed to the

highest standards and includes cGMP compliant manufacturing that adheres to

current IPEC excipient guidelines to support commercialization of the Company's

next generation of high-purity and multicompendial TRIS AMINO Ultra Pure

products for the life sciences markets.

"Since the original invention of the TRIS molecule, ANGUS has made significant

investments in expanding our capabilities and production capacity to meet the

increasing demand, and quality and compliance standards of the life sciences

and industrial markets that require this essential chemistry," said David

Neuberger, President and Chief Executive Officer. "Today, with the launch of

our new TRIS AMINO AC-grade buffer products, ANGUS not only underwrites the

fast-growing global demand with a second ANGUS manufacturing source for TRIS

AMINO tromethamine, we also are addressing a chronic industry challenge with

handling of these products."

For additional information or to request a sample of one or more of the TRIS

AMINO AC-grade products (

https://c212.net/c/link/?t=0&l=en&o=2847037-1&h=1108324993&u=https%3A%2F%2Fangus.com%2Fmarkets%2Flife-sciences%2Fbiotechnology%2Ftris-amino-ac&a=TRIS+AMINO+AC-grade+products

) for qualification, visit angus.com, or contact an ANGUS representative in

your region at info@angus.com.

ABOUT ANGUS CHEMICAL COMPANY

ANGUS Chemical Company is a leading global specialty and fine chemical company

dedicated to the development of novel chemistries that deliver enhanced product

and process performance across a wide range of applications in biotechnology,

paints and coatings, personal care, metalworking fluids, energy and other

industrial markets. The company innovates through its unique nitroalkane

chemistries, which are produced at fully integrated, ISO 9001-certified

manufacturing facilities in Sterlington, Louisiana, USA, and Ibbenburen,

Germany. ANGUS serves its global customers through six regional Customer

Applications Centers located in Chicago, Illinois; Paris, France; Sao Paulo,

Brazil; Singapore; Shanghai, China; and Mumbai, India. The company is privately

owned by Golden Gate Capital and is headquartered in Buffalo Grove, Illinois.

For more information, visit www.angus.com.

Follow ANGUS on Facebook (

https://c212.net/c/link/?t=0&l=en&o=2847037-1&h=2657562986&u=https%3A%2F%2Fwww.facebook.com%2FANGUSChemCo&a=Facebook

), Twitter (

https://c212.net/c/link/?t=0&l=en&o=2847037-1&h=4173982349&u=https%3A%2F%2Ftwitter.com%2Fanguschemco&a=Twitter

), and LinkedIn (

https://c212.net/c/link/?t=0&l=en&o=2847037-1&h=1254984580&u=http%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fangus-chemical-company&a=LinkedIn

).

FOR ADDITIONAL INFORMATION

ANGUS Media Relations                  

Scott C. Johnson

+1 847-808-3769

scjohnson@angus.com

SOURCE  ANGUS Chemical Company